INTERNATIONAL PATENT: CELON PHARMA S.A. FILES APPLICATION FOR "BISPECIFIC ANTI-AXL AND ANTI-PD-L1 ANTIBODIES AND THEIR USE IN THERAPY, PARTICULARLY IN THE TREATMENT OF NEOPLASM"

GENEVA, April 21 -- CELON PHARMA S.A. (ul. Ogrodowa 2A05-092 Łomianki) filed a patent application (PCT/PL2024/050076) for "BISPECIFIC ANTI-AXL AND ANTI-PD-L1 ANTIBODIES AND THEIR USE IN THERAPY, PARTICULARLY IN THE TREATMENT OF NEOPLASM" on Oct 10, 2024. With publication no. WO/2025/080151, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABRAMCZYK, Olga (Ul. Modlińska 1A05-100 Nowy Dwor Mazowiecki), SOWIŃSKA, Aleksandra (Ul. Aluzyjna 19/4603-149 Warszawa), LACEK, Krzysztof (Ul. Radzymińska 12/7303-752 ...